CNS Drugs Journal Issues Research Articles in March 2022 Edition
March 18, 2022
March 18, 2022
CHAM, Switzerland, March 18 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its March 2022 edition:
* COMT Inhibitors in the Management of Parkinson's Disease
* Efficacy and Safety of HSK3486 for Anesthesia/Sedation in Patients Undergoing Fiberoptic Bronchos . . .
* COMT Inhibitors in the Management of Parkinson's Disease
* Efficacy and Safety of HSK3486 for Anesthesia/Sedation in Patients Undergoing Fiberoptic Bronchos . . .